Topic resource collection
Approved comparison material connected to this topic.
8 resourcesRead both sides
The AHK-Cu protocol operates through a fundamentally different mechanism than finasteride or minoxidil. Finasteride blocks the enzyme 5α-reductase systemically, reducing DHT conversion throughout the body. Minoxidil is a potassiu…
| Administration Route | Bioavailability | CNS Penetration | Onset Time | Primary Target Tissues | Practical Considerations | Professional Assessment ||—|—|—|—|—|—|| Subcutaneous Injection | 60–70% systemic | Minimal (<5%) | 5–10…
What makes PTH biology fascinating is that the effect flips depending on how the hormone is delivered. A brief once-daily spike of PTH(1–34) tips the balance toward osteoblasts and net bone formation. Chronically high PTH — as in…
Thymalin Thymic peptide bioregulator. Upregulates thymic epithelial cell activity, increases naïve T-cell production 5–10mg subcutaneous daily for 10–20 days per cycle Immune markers improve within 7–14 days; skin repair effects …
Thymalin Thymic epithelial stimulation → increased thymulin secretion and naïve T-cell output 10mg subcutaneous weekly or twice weekly CD4+/CD8+ T-cell counts, immunoglobulin levels 8–12 weeks Critical for immune resilience. Addr…
Phase 1: Immune Reset 1–4 Thymalin 5–10mg subcutaneous, every other day Restores thymic T-cell differentiation and CD4+/CD8+ balance Begin here. Immune function is the foundation. Elevated systemic inflammation blunts MK-677 IGF-…
Topical retinoids alone Keratinocyte turnover, retinoic acid receptor activation Improved texture, reduced fine lines (surface-level) Cannot address systemic GH decline or immune dysregulation Oral collagen peptides Provide glyci…
20s Prevention, oxidative stress mitigation Thymalin 5mg, GHK-Cu 2mg, BPC-157 250–500mcg Thymalin 2×/week, GHK-Cu daily, BPC-157 daily 8–12 weeks Focuses on maintaining existing collagen density while clearing early oxidative dam…